{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:21:00Z","timestamp":1789593660180,"version":"build-2803163510"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annalsofvascularsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.avsg.2019.07.011","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T19:27:53Z","timestamp":1569526073000},"page":"234-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Endovascular Revascularization Incorporating Infrapopliteal Coronary Drug-Eluting Stents Improves Clinical Outcomes in Patients with Critical Limb Ischemia and Tissue Loss"],"prefix":"10.1016","volume":"63","author":[{"given":"Lauren A.","family":"Huntress","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2519-5137","authenticated-orcid":false,"given":"Arash","family":"Fereydooni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Dardik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naiem","family":"Nassiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2019.07.011_bib1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3400\/avd.tasc.15-01000","volume":"8","author":"Jaff","year":"2015","journal-title":"Ann Vasc Dis"},{"key":"10.1016\/j.avsg.2019.07.011_bib2","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacc.2012.04.035","article-title":"Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trial","volume":"60","author":"Rastan","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2019.07.011_bib3","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jvs.2011.07.099","article-title":"Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease","volume":"55","author":"Bosiers","year":"2012","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2019.07.011_bib4","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.jacc.2012.08.989","article-title":"A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial","volume":"60","author":"Scheinert","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2019.07.011_bib5","doi-asserted-by":"crossref","first-page":"e002376","DOI":"10.1161\/CIRCINTERVENTIONS.114.002376","article-title":"Percutaneous Transluminal Angioplasty and Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia (PADI) trial","volume":"9","author":"Spreen","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2019.07.011_bib6","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1583\/JEVT-12-3993R.1","article-title":"Long-term outcomes following primary drug-eluting stenting of infrapopliteal bifurcations","volume":"19","author":"Spiliopoulos","year":"2012","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2019.07.011_bib7","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jcin.2014.04.015","article-title":"Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trial","volume":"7","author":"Siablis","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2019.07.011_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4330\/wjc.v11.i1.13","article-title":"Current evidence of drug-elution therapy for infrapopliteal arterial disease","volume":"11","author":"Spiliopoulos","year":"2019","journal-title":"World J Cardiol"},{"key":"10.1016\/j.avsg.2019.07.011_bib9","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00270-013-0578-2","article-title":"Systematic review of infrapopliteal drug-eluting stents: a meta-analysis of randomized controlled trials","volume":"36","author":"Katsanos","year":"2013","journal-title":"Cardiovasc Interv Radiol"},{"key":"10.1016\/j.avsg.2019.07.011_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2013.08.003","article-title":"The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI)","volume":"59","author":"Mills","year":"2014","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2019.07.011_bib11","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.avsg.2019.07.011_bib12","doi-asserted-by":"crossref","first-page":"e011245","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.avsg.2019.07.011_bib13","series-title":"UPDATE: treatment of peripheral arterial disease with paclitaxel-coated balloons and paclitaxel-eluting stents potentially associated with increased mortality\u2014letter to health care providers","year":"2019"},{"key":"10.1016\/j.avsg.2019.07.011_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003219","article-title":"Design and rationale of the best Endovascular Versus Best Surgical Therapy for Patients with Critical Limb Ischemia (BEST-CLI) trial","volume":"5","author":"Menard","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.avsg.2019.07.011_bib15","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jvs.2014.11.045","article-title":"The Society for Vascular Surgery lower extremity threatened limb classification system based on Wound, Ischemia, and foot Infection (WIfI) correlates with risk of major amputation and time to wound healing","volume":"61","author":"Zhan","year":"2015","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2019.07.011_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2018.11.039","article-title":"Using the Society for Vascular Surgery Wound, Ischemia, and foot Infection classification to identify patients most likely to benefit from revascularization","volume":"70","author":"Mayor","year":"2019","journal-title":"J Vasc Surg"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089050961930737X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089050961930737X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:54:28Z","timestamp":1760187268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089050961930737X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":16,"alternative-id":["S089050961930737X"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2019.07.011","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endovascular Revascularization Incorporating Infrapopliteal Coronary Drug-Eluting Stents Improves Clinical Outcomes in Patients with Critical Limb Ischemia and Tissue Loss","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2019.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}